Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
Felipe Magalhaes Furtado, Hematologist at Sabin Medicina Diagnóstica, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cytometry Part B: Clinical Cytometry, adding:
“I am pleased to share our recently published article in Cytometry Part B: Clinical Cytometry: ‘Artificial intelligence-based screening of paroxysmal nocturnal hemoglobinuria clones: Development and comparative evaluation of machine learning models.’
This study explores the application of machine learning to flow cytometry, focusing on the identification of paroxysmal nocturnal hemoglobinuria (PNH) clones.
I would like to express my gratitude to the faculty and staff of the MBA USP/Esalq MBA in Data Science and Analytics at USP/ESALQ, whose teaching and support were fundamental to the development of this project.
I am also grateful to Grupo Sabin for making this research possible.
My sincere thanks also go to Alan Carvalho Dias, André Pinto, Adâmara S. G. Felício, Camila S. Nobre, Fernanda Resende, my co-authors, whose expertise, contributions, and collaboration were essential to making this work possible.
It is a particular honor to see this research published in Cytometry Part B, a journal that has made significant contributions to the field of clinical cytometry.
I hope our findings contribute to further discussions and developments in the application of artificial intelligence to laboratory medicine.”
Title: Artificial intelligence-based screening of paroxysmal nocturnal hemoglobinuria clones: Development and comparative evaluation of machine learning models
Authors: Felipe Magalhães Furtado, Fernanda de Oliveira Resende, Camila Santos Nobre, Alan Carvalho Dias, André Luiz Pinto, Adamara Felício
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics
-
Nov 14, 2026, 23:33Alexandros Makis: Exploring Vascular Mechanisms and Therapeutic Targets in β-Thalassemia
-
Nov 14, 2026, 23:32Kalyan Roy: Asundexian Approval Marks a Milestone in Targeted Anticoagulation
-
Nov 14, 2026, 23:32Julia Pitcher: Strengthening Legislative Efforts for the Sickle Cell and Thalassemia Community
-
Nov 14, 2026, 23:31Sidi Mohamed El Amine Benlazar: The Role of Cytoreductive Therapy in MPN-Associated Splanchnic Vein Thrombosis
-
Nov 14, 2026, 23:24Roxana González: Pathogenesis of Vascular Disease in Behcet’s Syndrome
-
Nov 14, 2026, 23:15Pierre Sabouret: Despite the NEJM Publication, I Still Prefer DOACs
-
Nov 14, 2026, 16:35Sultan Aydın Aslantaş: A Rare Coexistence of LAHPS and Bloom Syndrome in a Child
-
Nov 14, 2026, 16:27Nicolas Moniotte: Dual-Platform Gene Editing for Haemophilia A